Sort by
Keyphrases
C-terminal Region
10%
Chromosome X
100%
Derepression
10%
Diffuse Midline Glioma
10%
Enhancer of Zeste
10%
Enhancer of Zeste Homolog 2 (EZH2)
50%
Ependymoma
30%
Functional Domain
10%
H3K27M
100%
H3K27me3
20%
Histone
20%
Hypomethylation
10%
Immunocytochemistry
10%
Infant Patients
10%
Inhibitory Mechanism
10%
Inhibitory Proteins
100%
Mass Spectrometry
10%
Mechanism of Action
10%
Methyltransferase Activity
20%
Modeling Analysis
10%
Molecular Groups
10%
Neurodevelopment
10%
Novel Targeted Therapy
10%
Oncogenic Mechanisms
10%
Oncohistone
100%
Overexpressing
10%
Overexpression
10%
Peptide Model
10%
Peptide Sequencing
10%
Polycomb Repressive Complex 2 (PRC2)
100%
Poor Prognosis
10%
Posterior Fossa
50%
Posterior Fossa Ependymoma
100%
SET Domain
10%
Su(var)3-9
10%
Trithorax
10%
Tumor
40%
Upstream Open Reading Frame (uORF)
100%
Western Blot Assay
10%
Young children
10%
Biochemistry, Genetics and Molecular Biology
C-Terminus
10%
Derepression
10%
Enhancer Region
10%
Histone
20%
Histone H3
10%
Immunocytochemistry
10%
Lysine
10%
Mass Spectrometry
10%
Methyltransferase
20%
Nerve Cell Differentiation
10%
Open Reading Frame
100%
Peptide Sequence
10%
Polycomb Repressive Complex 2
100%
SET Domain
10%
Transcription Factor EZH2
50%
Western Blotting
10%
X Chromosome
100%